INDRAPRASTHA MEDICAL CORP.LTD. - 532150 - Announcement under Regulation 30 (LODR)-Newspaper Publication
Pursuant to Regulation 30 of SEBI (LODR) Regulations, 2015, we hereby submit copies of Public Notice for completion of dispatch of Notice of AGM and Annual Report of the 35th AGM, Remote e-voting and Book Closure, published on 29th August, 2023, in the "Financial Express", all India editions, in English language and in "Jansatta", Delhi edition, in Hindi language. INDRAPRASTHA MEDICAL CORP.LTD. - 532150 - Notice Of The 35Th Annual General Meeting (AGM)
Notice of 35th Annual General Meeting (AGM) to be held on 21st September, 2023 attached. The Notice of AGM and Annual Report have also been uploaded on the Company''s website. INDRAPRASTHA MEDICAL CORP.LTD. - 532150 - Reg. 34 (1) Annual Report.
Pursuant to Regulation 34(1)(a) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, the Annual Report of the Company for the financial year ended 31st March, 2023, along with the Notice of the 35th Annual General Meeting (AGM) to be held on 21st September, 2023, is attached. The said Annual Report and Notice of AGM have also been uploaded on the Company's website. Members may access the same at https://delhi.apollohospitals.com/annual-report/ INDRAPRASTHA MEDICAL CORP.LTD. - 532150 - Announcement under Regulation 30 (LODR)-Newspaper Publication
we hereby submit copies of the public notice of the 35th Annual General Meeting, published on 26th August, 2023, in the financial Express all India editions, in English Language and in Janatta Delhi edition in Hindi language. INDRAPRASTHA MEDICAL CORP.LTD. - 532150 - Announcement under Regulation 30 (LODR)-Newspaper Publication
we hereby submit copies of the public notice of the financial results, published on 5th August, 2023, in the Financial express, all India editions, in English Language and in Jansatta, Delhi edition, in Hindi language. INDRAPRASTHA MEDICAL CORP.LTD. - 532150 - Fixation Of Record/Book Closure Dates
The Register of Members and Share Transfer Books of the Company shall remains closed from Saturday 16th September, 2023 to Thursday 21st September, 2023 for the purpose of AGM and Declaration of Dividend INDRAPRASTHA MEDICAL CORP.LTD. - 532150 - Un-Audited Financial Results For The Quarter Ended 30Th June, 2023
we are enclosing hereby un-audited financial results for the quarter ended 30th June, 2023 along with a copy of the Limited Review Report by the Statutory Auditor of the Company. INDRAPRASTHA MEDICAL CORP.LTD. - 532150 - Board Meeting Outcome for Outcome Of The Board Meeting Held On 4Th August, 2023
This is to inform that the Board of Directors of the Company has, at its meeting held on Friday, 4th August, 2023 (i.e. today), inter-alia, considered and approved the following items: 1. The Un-audited Financial Results of the company for the quarter ended 30th June, 2023. 2. Change in Directorship - Resignation by Director 3. Convening Annual General Meeting 4. Fixation of Record/Book Closure Dates The Board meeting commenced at 3.00 p.m. and ended at 5:15 p.m. INDRAPRASTHA MEDICAL CORP.LTD. - 532150 - Board Meeting Intimation for Unaudited Financial Results For The Quarter Ended 30.06.2023
INDRAPRASTHA MEDICAL CORP.LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 04/08/2023 ,inter alia, to consider and approve Pursuant to Regulation 29 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, it is hereby informed that a meeting of the Board of Directors of the Company will be held on Friday, 4th August, 2023, inter-alia, to consider and approve, the unaudited financial results for the quarter ended 30th June, 2023. This is for your information and record. Thanking You, INDRAPRASTHA MEDICAL CORP.LTD. - 532150 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
Enclosed please find herewith a Certificate dated 8th July, 2023, issued by M/s. Link Intime India Private limited, Registrar & Share Transfer Agent of the company, for the quarter ended 30th June, 2023.